Verition Fund Management LLC Fate Therapeutics Inc Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.26 - $7.08 $119,560 - $259,659	36,675 New	36,675 $120,000
Q3 2023 Nov 14, 2023	BUY	$2.02 - $5.04 $106,361 - $265,376	52,654 New	52,654 $111,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $125,655 - $303,689	12,744 New	12,744 $128,000
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $610,199 - $820,656	-12,755 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $542,676 - $876,503	-9,156 Reduced 41.79%	12,755 $756,000
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $1.47 Million - $2.03 Million	21,911 New	21,911 $1.9 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $194M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.